3 Year Absolute Returns
73.47% ↑
NAV (₹) on 30 Mar 2026
27.34
1 Day NAV Change
-1.20%
Risk Level
Very High Risk
Rating
-
LIC MF Healthcare Fund is a Equity mutual fund categorized under Sector, offered by LIC Mutual Fund Asset Management Limited. Launched on 08 Feb 2019, investors can start with a minimum SIP of ₹100 or ... Read more
AUM
₹ 82.13 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 67.77% |
| Hospitals & Medical Services | 23.76% |
| Treps/Reverse Repo | 3.90% |
| Chemicals - Others | 3.14% |
| Chemicals - Organic - Benzene Based | 1.57% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 11.09% | ₹ 9.11 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 6.93% | ₹ 5.69 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 6.87% | ₹ 5.64 | Hospitals & Medical Services |
| Fortis Healthcare Ltd. | 4.94% | ₹ 4.06 | Hospitals & Medical Services |
| Divi's Laboratories Ltd. | 4.81% | ₹ 3.95 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 4.65% | ₹ 3.82 | Pharmaceuticals |
| Piramal Pharma Ltd. | 4.30% | ₹ 3.53 | Pharmaceuticals |
| Neuland Laboratories Ltd. | 4.04% | ₹ 3.32 | Pharmaceuticals |
| Treps | 3.90% | ₹ 3.20 | Others |
| Onesource Specialty Pharma Ltd. | 3.63% | ₹ 2.98 | Pharmaceuticals |
| Alkem Laboratories Ltd. | 3.44% | ₹ 2.82 | Pharmaceuticals |
| Cipla Ltd. | 3.21% | ₹ 2.64 | Pharmaceuticals |
| Navin Fluorine International Ltd. | 3.14% | ₹ 2.58 | Chemicals - Others |
| Abbott India Ltd. | 3.13% | ₹ 2.57 | Pharmaceuticals |
| Glenmark Pharmaceuticals Ltd. | 3.12% | ₹ 2.56 | Pharmaceuticals |
| Gland Pharma Ltd. | 3.12% | ₹ 2.56 | Pharmaceuticals |
| IPCA Laboratories Ltd. | 3.09% | ₹ 2.54 | Pharmaceuticals |
| Concord Biotech Ltd. | 3.05% | ₹ 2.51 | Pharmaceuticals |
| Metropolis Healthcare Ltd. | 2.74% | ₹ 2.25 | Hospitals & Medical Services |
| Artemis Medicare Services Ltd. | 2.73% | ₹ 2.24 | Hospitals & Medical Services |
| Mankind Pharma Ltd. | 2.35% | ₹ 1.93 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 2.23% | ₹ 1.83 | Hospitals & Medical Services |
| Dr Agarwal's Health Care Ltd. | 2.18% | ₹ 1.79 | Hospitals & Medical Services |
| Anthem Biosciences Ltd. | 2.16% | ₹ 1.78 | Pharmaceuticals |
| Global Health Ltd. | 2.07% | ₹ 1.70 | Hospitals & Medical Services |
| Acutaas Chemicals Ltd. | 1.65% | ₹ 1.36 | Pharmaceuticals |
| Vinati Organics Ltd. | 1.57% | ₹ 1.29 | Chemicals - Organic - Benzene Based |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | -5.88% | -3.32% | 7.37% | 20.15% |
| Category returns | -8.43% | -0.15% | 4.50% | 20.57% |
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Axis Quant Fund
Diversified
Regular
|
₹13.97 | -4.77% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
Axis Quant Fund
Diversified
Regular
|
₹13.97 | -4.77% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
Axis Quant Fund
Diversified
Regular
|
₹13.97 | -4.77% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
Quantum ESG Best In Class Strategy Fund - Direct Plan
Diversified
Direct
|
₹21.69 | -7.58% | 32.90% | 49.07% | ₹95 | 0.75% |
Very High
|
|
Invesco India ESG Integration Strategy Fund - Direct Plan
Sector
Direct
|
₹15.55 | -10.63% | 32.68% | 55.50% | ₹400 | 1.15% |
Very High
|
|
Taurus Banking And Financial Services Fund
Sector
Regular
|
₹47.79 | -4.61% | 32.60% | 51.71% | ₹12 | 2.49% |
Very High
|
|
Taurus Banking And Financial Services Fund
Sector
Regular
|
₹42.78 | -4.62% | 32.57% | 51.70% | ₹12 | 2.49% |
Very High
|
|
Taurus Banking And Financial Services Fund
Sector
Regular
|
₹42.78 | -4.62% | 32.57% | 51.70% | ₹12 | 2.49% |
Very High
|
|
HDFC Business Cycle Fund
Sector
Regular
|
₹12.58 | -6.38% | 32.45% | 0.00% | ₹2,650 | 2.00% |
Very High
|
|
HDFC Business Cycle Fund
Sector
Regular
|
₹12.58 | -6.38% | 32.45% | 0.00% | ₹2,650 | 2.00% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
LIC MF Aggressive Hybrid Fund - Direct Plan
Hybrid
Direct
|
₹19.77 | -1.48% | 32.37% | 24.43% | ₹518 | 1.41% |
Very High
|
|
LIC MF Aggressive Hybrid Fund - Direct Plan
Hybrid
Direct
|
₹19.77 | -1.48% | 32.37% | 24.43% | ₹518 | 1.41% |
Very High
|
|
LIC MF Large Cap Fund - Direct Plan
Diversified
Direct
|
₹55.37 | -5.82% | 31.56% | 50.72% | ₹1,422 | 1.10% |
Very High
|
|
LIC MF Large Cap Fund - Direct Plan
Diversified
Direct
|
₹34.87 | -5.83% | 31.53% | 43.93% | ₹1,422 | 1.10% |
Very High
|
|
LIC MF Large Cap Fund - Direct Plan
Diversified
Direct
|
₹34.87 | -5.83% | 31.53% | 43.93% | ₹1,422 | 1.10% |
Very High
|
|
LIC MF Equity Savings Fund - Direct Plan
Hybrid
Direct
|
₹30.31 | 3.14% | 31.33% | 43.49% | ₹36 | 1.34% |
Moderately High
|
|
LIC MF Equity Savings Fund - Direct Plan
Hybrid
Direct
|
₹20.47 | 3.13% | 31.27% | 34.00% | ₹36 | 1.34% |
Moderately High
|
|
LIC MF Equity Savings Fund - Direct Plan
Hybrid
Direct
|
₹20.47 | 3.13% | 31.27% | 34.00% | ₹36 | 1.34% |
Moderately High
|
|
LIC MF Equity Savings Fund - Direct Plan
Hybrid
Direct
|
₹16.89 | 3.13% | 31.26% | 32.13% | ₹36 | 1.34% |
Moderately High
|
|
LIC MF Equity Savings Fund - Direct Plan
Hybrid
Direct
|
₹16.89 | 3.13% | 31.26% | 32.13% | ₹36 | 1.34% |
Moderately High
|
What is the current NAV of LIC MF Healthcare Fund Regular IDCW-Reinvestment?
What is the fund size (AUM) of LIC MF Healthcare Fund Regular IDCW-Reinvestment?
What are the historical returns of LIC MF Healthcare Fund Regular IDCW-Reinvestment?
What is the risk level of LIC MF Healthcare Fund Regular IDCW-Reinvestment?
What is the minimum investment amount for LIC MF Healthcare Fund Regular IDCW-Reinvestment?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article